drugset / Trial / NCT01817270
Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine
Phase 4
Completed
368 enrolled
Changchun Keygen Biological Products Co., Ltd.
Guangdong Provincial Institute of Biological Products And Materia Medica · collab
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to observe the occurrence of adverse events, seroconversion rate and geometric mean titres(GMTs) of 2 doses of live attenuated varicella vaccine.
Timeline
- Start
- 2013-03
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Live Attenuated Varicella Vaccine | Vaccine | — | Other |